(Q37939730)

English

International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies

scientific article published on January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1 reference

based on heuristic

inferred from title

Pier Luigi Meroni

4

object named as

Pier Luigi Meroni

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Emmanuel J Favaloro

2

object named as

Emmanuel J Favaloro

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

5

object named as

Angela Tincani

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Eon Nigel Harris

3

object named as

E Nigel Harris

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Silvia S Pierangeli

7

object named as

Silvia S Pierangeli

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Gabriella Lakos

1

object named as

Gabriella Lakos

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

author name string

Richard C Wong

6

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

publication date

1 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1-10

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting.

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Assessing the variation in antiphospholipid antibody (APA) assays: comparison of results from 10 centers

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010.

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

A quarter of a century in anticardiolipin antibody testing and attempted standardization has led us to here, which is?

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Antiphospholipid antibody profile: implications for the evaluation and management of patients

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant.

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

IgA antiphospholipid antibodies are an independent risk factor for thromboses

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Isolated elevation of IgA anti-beta2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Antiphospholipid antibodies differ in aPL cofactor requirement

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Anomalous anticardiolipin antibody results may be due to cofactor variability

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Appropriate calibration curve fitting in ligand binding assays

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Traceability in laboratory medicine

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Use and interpretation of common statistical tests in method comparison studies.

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Clinical laboratory testing for the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

IgM-class rheumatoid factor interference in the solid-phase radioimmunoassay of rubella-specific IgM antibodies

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

False-positive test result for IgM anticardiolipin antibody due to IgM rheumatoid factor

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Accuracy of Anticardiolipin Antibodies in Identifying a History of Thrombosis Among Patients With Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FART.33349

21 January 2018

Identifiers

10.1002/ART.33349

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37939730&oldid=2101511809"